J&J Talcum Powder

On August 21, 2017 a Los Angeles jury awarded $417 million to Robinson Calcagnie client Eva Echeverria, finding a connection between her ovarian cancer and the Johnson & Johnson baby powder she used for decades. Our firm is representing Ms. Echeverria, along with hundreds of other women, both in California and across the nation, who have used talcum powder sold by Johnson & Johnson in their genital region and developed ovarian cancer. If you or a loved one has used Johnson & Johnson talcum powder and developed ovarian cancer, you may be eligible to file a claim. Contact the Robinson Calcagnie, Inc. law firm for a free and confidential evaluation.

The Relationship Between J&J Talcum Powder and Ovarian Cancer

There have been more than 20 studies published that show women who have used talc on their genitals are at an increased risk, up to 92% (according to a study performed in 1982) for ovarian cancer. In 1999, another study found that “avoidance of talc in genital hygiene might reduce the occurrence of a highly lethal form of cancer by at least 10%. The study also stated: “Appropriate warnings should be provided to women about the potential risks of regular use of talc in the genital area.”

Cases are currently coordinated in Los Angeles Superior Court, Johnson & Johnson Talcum Powder Cases, JCCP4872, where Mark P. Robinson Jr. serves as co-lead counsel, and in New Jersey Federal Court, Johnson & Johnson Talcum Powder Litigation, MDL 2738.